Author | Gina Columbus

Articles

Lenalidomide/Rituximab Combo Improves PFS in Subgroup of Patients with NHL

December 09, 2019

Treatment with lenalidomide and rituximab improved progression-free survival, compared with placebo in patients ≥70 years old with indolent non-Hodgkin lymphoma.

Acalabrutinib Regimens Improve PFS in Treatment-Naïve Patients with CLL

December 08, 2019

Acalabrutinib alone and in combination with obinutuzumab significantly improved progression-free survival, compared with obinutuzumab plus chlorambucil in treatment-naïve patients with chronic lymphocytic leukemia

Frontline Ibrutinib/Venetoclax Provides High Rates of Undetectable MRD in CLL

December 08, 2019

First-line treatment with ibrutinib plus venetoclax provided high rates of undetectable minimal residual disease in peripheral blood and bone marrow of patients with chronic lymphocytic leukemia.